Skip to content

Mobile Application Using Peak Expiratory Flow Rate to Guide Asthma Treatment.

Peak Expiratory Flow Rate -(PEFR)-An App For Asthma Treatment Titration. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104698
Enrollment
80
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J980- Diseases of bronchus, not elsewhere classified

Interventions

Intervention1: PEFR-Guided Asthma Treatment Titration Using a Mobile Application.: The intervention involves a Peak Expiratory Flow Rate (PEFR) based asthma treatment titration mobile application that

Sponsors

Saveetha Medical College And Hospitals.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 to 65 years 2.Clinically diagnosed bronchial asthma as per standard guidelines 3.Patients on regular controller therapy for asthma 4.Ability to perform acceptable and reproducible PEFR measurements 5.Ownership of and ability to use a smartphone capable of running the study application 6.Willingness to use the mobile application and perform daily PEFR recordings

Exclusion criteria

Exclusion criteria: 1.Age less than 18 years or more than 65 years 2.Acute severe asthma exacerbation requiring immediate hospitalization at enrollment 3.Coexisting chronic respiratory diseases (e.g., COPD, bronchiectasis, interstitial lung disease) 4.Significant smoking history 5.Inability to perform reliable PEFR maneuvers despite instruction 6.Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Improvement in asthma control measured by change in Asthma Control Test (ACT) score from baseline to the end of follow-up.Timepoint: 1st month, 2nd month, 3rd month, 4th month, 5th month, 6th month.

Secondary

MeasureTime frame
1.PEFR variability and zone control (mean PEFR, % days in green/yellow/red zone) 2.Asthma exacerbations and OCS use 3.Reliever (SABA) use 4.Medication adherence 5.Inhaler technique 6.Quality of life (AQLQ)Timepoint: 1st month, 2nd month, 3rd month, 4th month, 5th month, 6th month

Countries

India

Contacts

Public ContactVishnu Rs

Saveetha Medical College And Hospital

prasanthgd@gmail.com9788852770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026